Hsu CP - Search Results

1

AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma.

Lin CH, Chuang HN, Hsiao TH, Kumar VB, Hsu CH, Huang CY, Lee LW, Mao CL, Ko JL, Hsu CP. Lin CH, et al. Among authors: hsu cp, hsu ch. PLoS One. 2022 Nov 3;17(11):e0276990. doi: 10.1371/journal.pone.0276990. eCollection 2022. PLoS One. 2022. PMID: 36327302 Free PMC article.

2

Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma.

Hsia JY, Chen CY, Chen JT, Hsu CP, Shai SE, Yang SS, Chuang CY, Wang PY, Miaw J. Hsia JY, et al. Among authors: hsu cp. Eur J Surg Oncol. 2003 Feb;29(1):44-8. doi: 10.1053/ejso.2002.1338. Eur J Surg Oncol. 2003. PMID: 12559076

3

Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas.

Wu TC, Lin P, Hsu CP, Huang YJ, Chen CY, Chung WC, Lee H, Ko JL. Wu TC, et al. Among authors: hsu cp. Lung Cancer. 2003 Aug;41(2):163-9. doi: 10.1016/s0169-5002(03)00195-8. Lung Cancer. 2003. PMID: 12871779

4

Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines.

Weng MW, Lai JC, Hsu CP, Yu KY, Chen CY, Lin TS, Lai WW, Lee H, Ko JL. Weng MW, et al. Among authors: hsu cp. Environ Mol Mutagen. 2005 Jul;46(1):1-11. doi: 10.1002/em.20118. Environ Mol Mutagen. 2005. PMID: 15714438

5

Prognostic significance of intratumoral natural killer cells in primary resected esophageal squamous cell carcinoma.

Hsia JY, Chen JT, Chen CY, Hsu CP, Miaw J, Huang YS, Yang CY. Hsia JY, et al. Among authors: hsu cp. Chang Gung Med J. 2005 May;28(5):335-40. Chang Gung Med J. 2005. PMID: 16086548 Free article.

6

Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.

Liao CH, Hsiao YM, Hsu CP, Lin MY, Wang JC, Huang YL, Ko JL. Liao CH, et al. Among authors: hsu cp. Mol Carcinog. 2006 Apr;45(4):220-9. doi: 10.1002/mc.20161. Mol Carcinog. 2006. PMID: 16402390

7

Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus.

Hsu CP, Lee LW, Shai SE, Chen CY. Hsu CP, et al. World J Gastroenterol. 2005 Nov 28;11(44):6941-7. doi: 10.3748/wjg.v11.i44.6941. World J Gastroenterol. 2005. PMID: 16437597 Free PMC article.

8

Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.

Hsu CP, Shen GH, Ko JL. Hsu CP, et al. Lung Cancer. 2006 Jun;52(3):349-57. doi: 10.1016/j.lungcan.2006.01.011. Epub 2006 Mar 29. Lung Cancer. 2006. PMID: 16569461 Clinical Trial.

9

Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.

Hsu CP, Hsu NY, Lee LW, Ko JL. Hsu CP, et al. Among authors: hsu ny. Eur J Cancer. 2006 Jul;42(10):1466-74. doi: 10.1016/j.ejca.2006.02.014. Epub 2006 Jun 5. Eur J Cancer. 2006. PMID: 16737810

10

Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.

Hsu CP, Ko JL, Shai SE, Lee LW. Hsu CP, et al. Lung Cancer. 2007 Dec;58(3):310-6. doi: 10.1016/j.lungcan.2007.06.019. Epub 2007 Aug 2. Lung Cancer. 2007. PMID: 17681636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

529 results

Search Page

Filters